Application of median-effect in quantitative analysis of antitumor drugs in vitro

Chinese Journal of Cancer Research

Volumn 17, Issue 2, 2005, Pages 140-144

  He, Song ^a   Shen, Wei ^a   Shen, Ding Ming ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

5 Fluorouracil; Combination index (CI); Median effect principle; Oxymatrine (OMT); Quantitative analysis in vitro

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; OXYMATRINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL KILLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; QUANTITATIVE ANALYSIS;

EID: 21444443794     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-005-0060-z     Document Type: Article

References (15)

1. Chou TC, Talalay P. Quantitative analysis of dose-effects relationships: the combined effect of multiple drugs on enzyme inhibitors [J]. Adv Enzyme Regul 1984; 22: 27-55.
2. Ting-Chao Chou, Robert JM, You Zhi Tong, et al. Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human terato-carcinoma cell growth: a rational approach to clinical protocal design[J]. J Nat Cancer Inst 1994; 86: 1517-24.
3. Scott MK, David P, Christopher AB, et al. Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines[J]. J Nat Cancer Inst 1996; 88: 734-41.
4. Hayley MM, Patrick GJ. Synergistic interaction between paclitaxel and 8-chloro-adenosine 3′ 5′-monophosphate in human ovarian carcinoma cell lines[J]. Clin Cancer Res 1999; 5: 215-20.
5. Tang WX, Cheng PY, Luo YP, et al. Interaction between cisplatin, 5-fluorouracil and vincristine on human hepatoma cell line(7721)[J]. World J Gastroenterol 1998; 4: 418-20.
6. Sotto A, Foulongne V, Sirot D, et al. Experimental application of the median-effecdt principle for in vitro quantification of the combined inhibitory activities of clavulanic acid and imipenem against IRT-4 beta-lactamase[J]. Int J Antimicrob Agents 2002; 19: 75-8.
7. He S, Chen S, Tang WX, et al. The interaction between 5-fluorouracil and matrine on QGY cell line in vitro[J]. Chin J Hepatol 2002; 10: 160.
8. Tang WX, Luo YP, wang RX. Establishment of MTT method for testing anticancer drug sensitivity on human tumor[J]. J Chongqing Med Univ 1992; 17: 103-8.
9. Li D, Wang PQ, zhang NS, et al. Progress in research of matrine-type alkaloid and its clinical application[J]. Chin Trad Herbal Drugs 1996; 27: 308-10.
10. Luo M, He P, Wu MCh, et al. Prevention and retarding effect of matrine and matrine oxide on liver cancer on rats caused by diethyl nitrosamine[J]. Chin J Cancer Prev Treat 2000; 7: 561-3.
11. Liu YH, Liu YF, Guo XX. Current studies on anti-endotoxic chemical components of traditional Chinese medicine in China[J]. Acta Pharmacol Sin 2001; 22: 1071-7.
12. Lo WL, Chang FR, Liaw CC, et al. Cytotoxic coumaronochromones from the roots of Euchresta formosana[J]. Planta Med 2002; 68: 146-51.
13. Liu M, Liu XY, Cheng JF. Advance in the pharmacological research on matrine[J]. China J Chin Materia Med 2003; 28: 801-4.
14. Long Y, Lin XT, Zeng KL, et al. Efficacy of intramuscular matrine in the treatment of chronic hepatitis B[J]. Hepatobiliary Pancreat Dis Int 2004; 3: 69-72.
15. Xu CQ, Dong DL, Du ZM, et al. Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866[J]. Aca Pharm Sin 2004; 39: 691-4.